<bill session="115" type="h" number="4138" updated="2023-01-11T13:38:22Z">
  <state datetime="2017-10-26">REFERRED</state>
  <status>
    <introduced datetime="2017-10-26"/>
  </status>
  <introduced datetime="2017-10-26"/>
  <titles>
    <title type="display">Medicare Drug Price Negotiation Act</title>
    <title type="short" as="introduced">Medicare Drug Price Negotiation Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="C000984"/>
  <cosponsors>
    <cosponsor bioguide_id="B001278" joined="2018-07-17"/>
    <cosponsor bioguide_id="C001068" joined="2017-10-26"/>
    <cosponsor bioguide_id="D000216" joined="2017-10-26"/>
    <cosponsor bioguide_id="D000399" joined="2017-10-26"/>
    <cosponsor bioguide_id="E000288" joined="2017-10-26"/>
    <cosponsor bioguide_id="G000571" joined="2017-10-26"/>
    <cosponsor bioguide_id="G000551" joined="2017-10-26"/>
    <cosponsor bioguide_id="H001038" joined="2017-10-26"/>
    <cosponsor bioguide_id="J000298" joined="2017-10-26"/>
    <cosponsor bioguide_id="K000009" joined="2017-10-26"/>
    <cosponsor bioguide_id="K000389" joined="2017-10-26"/>
    <cosponsor bioguide_id="K000391" joined="2018-12-13"/>
    <cosponsor bioguide_id="M001185" joined="2018-11-13"/>
    <cosponsor bioguide_id="N000002" joined="2017-10-26"/>
    <cosponsor bioguide_id="N000147" joined="2017-10-26"/>
    <cosponsor bioguide_id="O000170" joined="2017-10-26"/>
    <cosponsor bioguide_id="P000607" joined="2017-10-26"/>
    <cosponsor bioguide_id="R000606" joined="2017-11-29"/>
    <cosponsor bioguide_id="S001145" joined="2017-10-26"/>
    <cosponsor bioguide_id="S001170" joined="2017-10-26"/>
    <cosponsor bioguide_id="W000800" joined="2017-10-26"/>
  </cosponsors>
  <actions>
    <action datetime="2017-10-26">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-10-26" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-26">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2017-10-27">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="s" number="252" relation="unknown"/>
    <bill session="115" type="s" number="2011" relation="identical"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Congressional oversight"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Inflation and prices"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2019-08-05T17:49:51Z" status="Introduced in House">Medicare Drug Price Negotiation Act

This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans, including requirements relating to rebates for low-income individuals and drug price negotiations.</summary>
</bill>
